from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3787c/-

LFCtreatmentdescriptionclass of inhibitor

0.893

Amikacinug/mL Amikacintranslation

0.981

Cap5-10ug/mL Capreomycintranslation

-0.036

Rox10-50 ug/mL Roxithromycintranslation

0.563

SM2-5 ug/mL Streptomycintranslation

-0.988

Tet5-10 ug/mL Tetracyclinetranslation

-0.877

Rif0.2-5ug/mL Rifampicintranscription

0.496

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.266

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.768

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.077

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.804

Clofazimine10-13 ug/mL Clofaziminerespiration

0.362

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.685

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.257

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.477

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.085

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.027

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.502

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.091

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.185

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.277

KCN5-20 ug/mL Potassium cyaniderespiration

-0.378

NaN30.2-2 mM Sodium aziderespiration

1.570

Nigericin50 uM Nigericinrespiration

-0.289

TRC10-150 ug/mL Triclosanrespiration

-1.267

TRZ10-25 ug/mL Thioridazinerespiration

-0.795

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.018

menadione6-10 ug/mL Menadionerespiration

-0.290

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.557

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.037

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.897

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.026

NRP_1Non-replicating persistence stage 1dosRassociated

0.576

Amp0.2mg/mL AmpicillincellWall

0.191

Cephalexin20-100 ug/mL CephalexincellWall

1.605

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.147

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.109

EMB10-20 ug/mL EthambutolcellWall

0.541

Eta12-40 ug/mL EthionamidecellWall

0.403

INH0.2-0.4 ug/mL IsoniazidcellWall

0.333

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.629

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.544

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.180

BZA0.12 mg/mL BenzamidearomaticAmides

-0.570

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.448

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.197

H2O24 mM hydrogen peroxideDNAdamaging

0.340

Levo10 ug/mL LevofloxacinDNAdamaging

0.029

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.615

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.922

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.066

UVUV-irradiationDNAdamaging

-0.218

ARP41-4 ug/mL Antitubercular compound ARP4?

0.798

Antimycin12.5-50 ug/mL Antimycin A?

0.847

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.209

PA_110-50 ug/mL Antitubercular compound PA-1?

0.314

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.393

PA8240.2-2 ug/mL PA-824?

-0.453

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.004

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.023

Verapamil50 uM Verapamil?

0.444

mercaptoethanol2 mM 2-Mercaptoethanol?

0.913

methoxatin10-20 ug/mL Methoxatin?